The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow
- PMID: 3426918
- PMCID: PMC2001900
- DOI: 10.1038/bjc.1987.241
The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow
Abstract
The transplantable C57BL/KaLwRij mouse 5T2 multiple myeloma (MM) is a new animal model for studies on MM in man. Histological examination of the 5T2 MM cells revealed their morphological heterogeneity. In this study we investigated whether this heterogeneity reflects subpopulations of 5T2 MM cells with different biological properties. 5T2 MM bone marrow cells were separated according to their sedimentation velocity (s.v.). When intravenously injected into syngeneic recipient mice, cells with s.v. of 8 mm h-1 led to the development of detectable 5T2 MM after 6 weeks; in contrast, 18 weeks elapsed before the same result was achieved with cells of s.v. lower than 5 mm h-1. Flow cytometric analysis revealed that 5T2 MM cells had an aneuploid DNA content and that most cycling 5T2 MM cells were large, their s.v. rate exceeding 9 mm h-1. It was further demonstrated that about half of all aneuploid cells carried on their membrane the 5T2 MM idiotype. The majority of the idiotype-positive cells had s.v. rate exceeding 6.5 mm h-1 (16%-39%) or lower than 3 mm h-1 (16%-19%). The 5T2 MM was shown to contain subpopulations of cells of different size, proliferation capacity and expression of their membrane 5T2 idiotype; this, most likely reflects cells in different stages of differentiation. The mouse 5T2 MM corresponds also in this respect with MM in man.
Similar articles
-
Immune regulation of mouse 5T2 multiple myeloma. I. Immune response to 5T2 MM idiotype.Neoplasma. 1991;38(5):457-66. Neoplasma. 1991. PMID: 1956463
-
Immune regulation of 5T2 mouse multiple myeloma. II. Immunological treatment of 5T2 MM residual disease.Neoplasma. 1991;38(5):467-74. Neoplasma. 1991. PMID: 1956464
-
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse.Br J Cancer. 1997;76(4):451-60. doi: 10.1038/bjc.1997.409. Br J Cancer. 1997. PMID: 9275021 Free PMC article.
-
The use of animal models in multiple myeloma.Morphologie. 2015 Jun;99(325):63-72. doi: 10.1016/j.morpho.2015.01.003. Epub 2015 Apr 17. Morphologie. 2015. PMID: 25898798 Review.
-
Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.Verh K Acad Geneeskd Belg. 2003;65(2):127-34. Verh K Acad Geneeskd Belg. 2003. PMID: 12870183 Review.
Cited by
-
Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease.JBMR Plus. 2024 Jul 12;8(9):ziae093. doi: 10.1093/jbmrpl/ziae093. eCollection 2024 Sep. JBMR Plus. 2024. PMID: 39108360 Free PMC article.
-
A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse.Br J Cancer. 1992 Dec;66(6):1088-93. doi: 10.1038/bjc.1992.415. Br J Cancer. 1992. PMID: 1457349 Free PMC article.
-
Immunological dysregulation in multiple myeloma microenvironment.Biomed Res Int. 2014;2014:198539. doi: 10.1155/2014/198539. Epub 2014 Jun 11. Biomed Res Int. 2014. PMID: 25013764 Free PMC article. Review.
-
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.PLoS One. 2020 Jan 29;15(1):e0228408. doi: 10.1371/journal.pone.0228408. eCollection 2020. PLoS One. 2020. PMID: 31995627 Free PMC article.
-
Animal Models of Bone Metastasis.Vet Pathol. 2015 Sep;52(5):827-41. doi: 10.1177/0300985815586223. Epub 2015 May 28. Vet Pathol. 2015. PMID: 26021553 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical